IONS, AZN Stocks Fall On Full Data From Failed Cardiomyopathy Trial — Jefferies Sees Neutral To Negative Readthrough To ALNY

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.